| Particulars |
| Company Name |
Astrazeneca Pharma India Ltd |
| Face Value |
2 |
| BSE Code |
506820 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
5.00 |
| B.V. Rs |
319.60 |
| Sales Rs in Cr. |
1,716.29 |
| NP Rs in Cr. |
175.13 |
| NP Var% |
17.00 |
| Div% |
1,600.00 |
| CPS Rs |
86.00 |
| EPS Rs |
70.10 |
| Traded Value(Rs in Lakhs) |
22.59 |
| 52 Week High |
10,653.00 |
| 52 Week Low |
6,502.00 |
| Price BSE |
8,465.00 |
| Price NSE |
8,465.00 |
| Market Capital(Rs in Cr.) |
21,161.75 |
| P/C Ratio |
98.40 |
| P/E Ratio |
120.80 |
| Price Vs.BV |
26.49 |
| Latest Quarter |
| Year End |
202509 |
| Sales Rs in Cr. |
559.09 |
| NP Rs in Cr. |
58.13 |
| NP Var % |
51.00 |
| Trailing Twelve Months |
| Year End |
202509 |
| Sales |
1,484.51 |
| OPM |
9.59 |
| NP |
128.73 |
| NP Var% |
79.57 |
| EPS |
92.47 |
| PE |
91.54 |
|